News Release

<< Back

SurModics to Webcast Shareholders Annual Meeting on February 4

Webcast is Live at 4:00 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Jan. 22, 2014-- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and in vitro diagnostic technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, February 4, at 4:00 p.m. CT (5:00 p.m. ET).

Gary Maharaj, chief executive officer; Andy LaFrence, vice president of finance and chief financial officer; and Bob Buhrmaster, chairman of the board, will provide an overview of the broad outlook for the Company, and discuss financial results and achievements for the fiscal year ended September 30, 2013, as well as results from the first quarter of fiscal year 2014.

To access the webcast, go to https://www.virtualshareholdermeeting.com/SRDX five minutes prior to the start of the meeting to log in. In addition, the Annual Meeting audio and slide presentation will be archived on the Company’s website following the meeting.

About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance the well-being of patients by providing the world’s foremost, innovative surface modification technologies and in vitro diagnostic chemical components. The Company partners with the world’s leading and emerging medical device, diagnostic and life science companies to develop and commercialize innovative products designed to improve patient diagnosis and treatment. Core offerings include surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and microarrays. SurModics is headquartered in Eden Prairie, Minnesota. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this press release or part of any filings that the Company makes with the SEC.

Source: SurModics, Inc.

SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com